TLZ-RT develops synthetic and biological biomaterials, e.g. (µ- and nano-) particles, fibers (RENACER®) and coatings for regenerative medicine, tissue engineering and diagnostics. A core concern is to cover the entire value chain, starting from R&D tasks, through the up-scaling process, preclinical evaluation to the clinical phase.
We have the infrastructure and know-how to manufacture and process biomaterials on a pilot scale. Expertise in the implementation of automated processes for material synthesis, if necessary under GMP conditions, and services for biocompatibility testing according to DIN EN ISO 10933 and in more complex human-based 3D in vitro models, which enable predictive statements as an alternative to animal models, complete the range of services.
Current activities focus on biohybrid and biodegradable materials with biofunctionalization, biologized surface or properties for controlled drug delivery.